Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

UBS and Rand Merchant Bank top M&A financial advisers in Middle East & Africa region during Q1 2025, reveals GlobalData

UBS and Rand Merchant Bank were the top mergers and acquisitions (M&A) financial advisers in the Middle East & Africa region during the first quarter (Q1) of 2025 by value and volume, respectively, according to the latest financial advisers league table by GlobalData, a leading data and analytics company. An analysis of GlobalData’s Deals Database […]
Read more

Singapore oncology landscape set for disruption with ultrasound-based histotripsy trials, says GlobalData

Singapore’s oncology landscape is set to experience a transformative shift with the introduction of non-invasive, ultrasound-based histotripsy technology, supported by healthcare collaborations aimed at improving outcomes for liver, kidney, and pancreatic cancer patients. These advancements will help Singapore strengthen its position in global cancer research and innovation, says GlobalData, a leading data and analytics company. […]
Read more

Embedded insurance emerges as game-changer in personal lines distribution, finds GlobalData

Embedded insurance is rapidly emerging as the most promising distribution model for personal lines, outpacing traditional channels. By integrating coverage seamlessly at the point of sale, it enhances customer convenience and boosts conversion rates. As digital ecosystems evolve, insurers that embrace embedded strategies will gain a competitive edge in reaching previously untapped and time-conscious consumer […]
Read more

Travel and tourism sees resilient M&A activity amid 5% dip in overall deal volume in Q1 2025, reveals GlobalData

Deal-making in the travel and tourism sector showed signs of cautious optimism in the first quarter (Q1) of 2025, with overall activity experiencing only around 5% year-on-year (YoY) dip. While venture financing and private equity deals declined, mergers and acquisitions saw modest growth, highlighting investor selectivity and regional resilience as key themes amid the evolving […]
Read more

Innovent’s Sycume to transform thyroid eye disease treatment landscape in China and Asia, says GlobalData

Innovent Biologics has recently received approval for Sycume (teprotumumab biosimilar) to treat thyroid eye disease (TED) in China. It is the country’s first insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody approved for TED by the National Medical Products Administration (NMPA). It represents a significant breakthrough and has the potential to transform the standard of […]
Read more

COPD market to surpass $30.2 billion in 7MM in 2033, driven by biologics and precision medicine, forecasts GlobalData

The chronic obstructive pulmonary disease (COPD) market across the seven major markets (7MM*), is projected to grow from $11.6 billion in 2023 to $30.2 billion in 2033, representing a compound annual growth rate (CAGR) of 10%, driven by the entry of biologics into the treatment landscape and the continued integration of precision medicine approaches, forecasts […]
Read more

US card payments market growth to slow in 2025 amid tariffs and inflationary pressures, forecasts GlobalData

The US card payments market is projected to grow by a modest 2.4% in 2025, reaching $10.8 trillion, as economic uncertainty and rising tariffs weigh on consumer spending. While strong foundations like high card penetration and contactless adoption persist, inflationary pressures and trade disruptions are expected to challenge the market’s resilience and slow its previously […]
Read more

US tariffs drive enterprise IT shift toward cloud and AI-driven digital transformation, finds GlobalData

The US administration’s tariff policies are reshaping global trade dynamics, triggering uncertainty across industries. For the IT services market, this means supply chain disruptions, delayed hardware projects, and cautious enterprise spending. Yet, amid volatility, digital transformation remains a strategic imperative. Enterprises embracing cloud, artificial intelligence (AI), and automation are better positioned to adapt swiftly and […]
Read more

Indonesia’s e-commerce market to surpass $46 billion in 2025, forecasts GlobalData

Indonesia’s e-commerce market is witnessing rapid growth, driven by rising internet penetration, smartphone usage, and a growing middle class. Online shopping festivals, payment innovations, and mobile wallet adoption are fueling consumer demand. Government efforts to boost digital infrastructure and transaction security are further accelerating the shift. Against this backdrop, the market is projected to reach […]
Read more

Remegen eyes competitive DMT market as telitacicept shows promise in gMG, says GlobalData

At the recently held 2025 American Academy of Neurology (AAN) meeting, Remegen presented positive Phase III results for telitacicept in patients with AChR+ or MuSK+ generalized myasthenia gravis (gMG). The B cell-targeting therapy demonstrated a favorable efficacy and safety profile over 24 weeks, showing clinically meaningful improvement. These findings position telitacicept as a potential challenger […]
Read more

Australia mammography equipment market poised for 7% CAGR through 2034, forecasts GlobalData

Australia’s breast cancer screening landscape is evolving, with innovation in imaging and complementary diagnostics driving a shift toward more personalized care. While mammography remains the cornerstone, new technologies such as lipid-based blood tests are improving detection in patients with dense breast tissue. This progress is expected to fuel steady growth in the mammography equipment market, […]
Read more

OX40 inhibitors may transform atopic dermatitis landscape, says GlobalData

The atopic dermatitis (AD) treatment landscape is witnessing intensified competition with several novel therapies nearing market entry. While biologics like dupilumab have already transformed care, emerging drug classes such as OX40 inhibitors are showing promise in clinical trials. Their potential for long-lasting efficacy and favorable safety profiles may significantly advance treatment options for moderate-to-severe AD […]
Read more

Trump’s tariff U-turn drives 550% surge in influencer debate amid deep divide, finds GlobalData

President Donald Trump hit a 90-day pause on tariffs for key US trade partners, except China. The unexpected move reversed his hardline stance, triggered a market rally, and eased global trade tensions. Consequently, the conversation related to ‘Tariffs’ among the influencers week-on-week surged by 550%, in the second week of April, reveals the Social Media […]
Read more
1 … 33 34 35 36 37 … 209